<?xml version="1.0"?>
<case>
<name>Kinabalu Investments Pty Ltd v Barron &amp; Rawson Pty Ltd (includes corrigendum dated 28 March 2008 and 17 March 2008) [2008] FCA 314 (11 March 2008)</name>
<AustLII>http://www.austlii.edu.au/au/cases/cth/FCA/2008/314.html</AustLII>
<citphrases>
<citphrase id="cp0.0" type=cited from="[2006] FCA 1216">patents</citphrase>
<citphrase id="cp0.1" type=cited from="[2006] FCA 1216">unjustified threats of infringement of chemical patent</citphrase>
<citphrase id="cp0.2" type=cited from="[2006] FCA 1216">first respondent owns patents for complexes, methods and products designed to treat dental caries</citphrase>
<citphrase id="cp0.3" type=cited from="[2006] FCA 1216">sent letters to third parties alleging that products manufactured by applicant infringed patents owned by first respondent patents</citphrase>
<citphrase id="cp0.4" type=cited from="[2006] FCA 1216">infringement</citphrase>
<citphrase id="cp0.5" type=cited from="[2006] FCA 1216">counter-claim by respondents that applicant infringed the first respondent's patents</citphrase>
<citphrase id="cp0.6" type=cited from="[2006] FCA 1216">whether integers of the claim are present in the applicant's products</citphrase>
<citphrase id="cp0.7" type=cited from="[2006] FCA 1216">construction of patent claim</citphrase>
<citphrase id="cp0.8" type=cited from="[2006] FCA 1216">whether extraction and isolation of phosphopeptide must be deliberate</citphrase>
<citphrase id="cp0.9" type=cited from="[2006] FCA 1216">whether complex must have been stabilized by the phosphopeptide at the moment of formation  patents</citphrase>
<citphrase id="cp0.10" type=cited from="[2006] FCA 1216">validity</citphrase>
<citphrase id="cp0.11" type=cited from="[2006] FCA 1216">novelty</citphrase>
<citphrase id="cp0.12" type=cited from="[2006] FCA 1216">cross-claim by applicant that patents are invalid</citphrase>
<citphrase id="cp0.13" type=cited from="[2006] FCA 1216">whether prior disclosures contain all integers of claim</citphrase>
<citphrase id="cp0.14" type=cited from="[2006] FCA 1216">whether disclosures contains clear and unmistakable instructions as to how to use the claimed invention</citphrase>
<citphrase id="cp0.15" type=cited from="[2006] FCA 1216">whether disclosures were publicly available</citphrase>
<citphrase id="cp0.16" type=cited from="[2006] FCA 1216">whether first respondent consented to publication patents</citphrase>
<citphrase id="cp0.17" type=cited from="[2006] FCA 1216">validity</citphrase>
<citphrase id="cp0.18" type=cited from="[2006] FCA 1216">inventive step</citphrase>
<citphrase id="cp0.19" type=cited from="[2006] FCA 1216">whether invention obvious to a person skilled in the art in light of the common general knowledge at the priority date</citphrase>
<citphrase id="cp0.20" type=cited from="[2006] FCA 1216">whether common general knowledge included knowledge of cluster sequence and its function in binding calcium phosphate</citphrase>
<citphrase id="cp0.21" type=cited from="[2006] FCA 1216">whether common general knowledge taught formation of casein phosphopeptide complexes at a ph greater than 7  patents</citphrase>
<citphrase id="cp0.22" type=cited from="[2006] FCA 1216">validity</citphrase>
<citphrase id="cp0.23" type=cited from="[2006] FCA 1216">false suggestion</citphrase>
<citphrase id="cp0.24" type=cited from="[2006] FCA 1216">first respondent made a false submission to the patent office as to the state of the prior art</citphrase>
<citphrase id="cp0.25" type=cited from="[2006] FCA 1216">whether submission constitutes a false suggestion patents</citphrase>
<citphrase id="cp0.26" type=cited from="[2006] FCA 1216">validity</citphrase>
<citphrase id="cp0.27" type=cited from="[2006] FCA 1216">fair basis</citphrase>
<citphrase id="cp0.28" type=cited from="[2006] FCA 1216">whether patent specification is clear, succinct and fairly based on the matter described in the specification trade practices</citphrase>
<citphrase id="cp0.29" type=cited from="[2006] FCA 1216">misleading and deceptive conduct</citphrase>
<citphrase id="cp0.30" type=cited from="[2006] FCA 1216">first respondent alleges applicant made representations that studies revealed that its products had a similar anti-caries effect to the first respondent's products</citphrase>
<citphrase id="cp0.31" type=cited from="[2006] FCA 1216">whether representations were misleading or deceptive as to the qualities of the goods</citphrase>
<citphrase id="cp1.0" type=cited from="[2005] FCAFC 224">patents</citphrase>
<citphrase id="cp1.1" type=cited from="[2005] FCAFC 224">validity</citphrase>
<citphrase id="cp1.2" type=cited from="[2005] FCAFC 224">construction</citphrase>
<citphrase id="cp1.3" type=cited from="[2005] FCAFC 224">lack of inventive step</citphrase>
<citphrase id="cp1.4" type=cited from="[2005] FCAFC 224">novelty</citphrase>
<citphrase id="cp1.5" type=cited from="[2005] FCAFC 224">fair basis</citphrase>
<citphrase id="cp1.6" type=cited from="[2005] FCAFC 224">sufficiency of description of invention</citphrase>
<citphrase id="cp1.7" type=cited from="[2005] FCAFC 224">disclosure of best method of invention</citphrase>
<citphrase id="cp1.8" type=cited from="[2005] FCAFC 224">date of assessment</citphrase>
<citphrase id="cp1.9" type=cited from="[2005] FCAFC 224">false suggestion</citphrase>
<citphrase id="cp1.10" type=cited from="[2005] FCAFC 224">patent for treatment of erectile dysfunction</citphrase>
<citphrase id="cp1.11" type=cited from="[2005] FCAFC 224">common general knowledge at priority date</citphrase>
<citphrase id="cp1.12" type=cited from="[2005] FCAFC 224">relevant prior art</citphrase>
<citphrase id="cp1.13" type=cited from="[2005] FCAFC 224">use of evidence of overseas witnesses</citphrase>
<citphrase id="cp2.0" type=cited from="[2005] FCA 805">patent</citphrase>
<citphrase id="cp2.1" type=cited from="[2005] FCA 805">appeal from dismissal of opposition by commissioner of patents</citphrase>
<citphrase id="cp2.2" type=cited from="[2005] FCA 805">burden of proof where extensive evidence</citphrase>
<citphrase id="cp2.3" type=cited from="[2005] FCA 805">whether obviousness evidence assessed on balance of probabilities</citphrase>
<citphrase id="cp2.4" type=cited from="[2005] FCA 805">multi-hull seagoing vessels</citphrase>
<citphrase id="cp2.5" type=cited from="[2005] FCA 805">novelty</citphrase>
<citphrase id="cp2.6" type=cited from="[2005] FCA 805">anticipation</citphrase>
<citphrase id="cp2.7" type=cited from="[2005] FCA 805">essential and inessential integers</citphrase>
<citphrase id="cp2.8" type=cited from="[2005] FCA 805">"substantial portion" in claim understood in context of whole specification</citphrase>
<citphrase id="cp2.9" type=cited from="[2005] FCA 805">evidence on normal meaning of terms not relevant</citphrase>
<citphrase id="cp2.10" type=cited from="[2005] FCA 805">precise mathematical parameters in claims</citphrase>
<citphrase id="cp2.11" type=cited from="[2005] FCA 805">whether differences said to be not material to performance are included in mathematical criteria</citphrase>
<citphrase id="cp2.12" type=cited from="[2005] FCA 805">whether made essential</citphrase>
<citphrase id="cp2.13" type=cited from="[2005] FCA 805">not a case for purposive construction</citphrase>
<citphrase id="cp2.14" type=cited from="[2005] FCA 805">mechanical equivalence of inessential not essential integers</citphrase>
<citphrase id="cp2.15" type=cited from="[2005] FCA 805">whether claims permit a 2% variation said to be within operational functions and of no practical significance</citphrase>
<citphrase id="cp2.16" type=cited from="[2005] FCA 805">hindsight in evidence of disclosure of prior publication</citphrase>
<citphrase id="cp2.17" type=cited from="[2005] FCA 805">fact that witness aware of patent specified not of itself sufficient to disregard evidence</citphrase>
<citphrase id="cp2.18" type=cited from="[2005] FCA 805">lack of inventive step and obviousness</citphrase>
<citphrase id="cp2.19" type=cited from="[2005] FCA 805">assertion that prior art vessels essentially achieved solution although not within claimed parameters</citphrase>
<citphrase id="cp2.20" type=cited from="[2005] FCA 805">hindsight</citphrase>
<citphrase id="cp2.21" type=cited from="[2005] FCA 805">manner of manufacture</citphrase>
<citphrase id="cp2.22" type=cited from="[2005] FCA 805">whether claims limited to exemplified embodiments</citphrase>
<citphrase id="cp2.23" type=cited from="[2005] FCA 805">utility</citphrase>
<citphrase id="cp2.24" type=cited from="[2005] FCA 805">embodiments within the claims that are not useful and would not be considered</citphrase>
<citphrase id="cp2.25" type=cited from="[2005] FCA 805">proper construction of claims</citphrase>
<citphrase id="cp2.26" type=cited from="[2005] FCA 805">whether all embodiments fulfil the promised advantages of the invention</citphrase>
<citphrase id="cp2.27" type=cited from="[2005] FCA 805">fair basis</citphrase>
<citphrase id="cp2.28" type=cited from="[2005] FCA 805">clarity</citphrase>
<citphrase id="cp3.0" type=cited from="[2005] FCA 788">patent</citphrase>
<citphrase id="cp3.1" type=cited from="[2005] FCA 788">infringement</citphrase>
<citphrase id="cp3.2" type=cited from="[2005] FCA 788">mechanical combination</citphrase>
<citphrase id="cp3.3" type=cited from="[2005] FCA 788">principles of claim construction</citphrase>
<citphrase id="cp3.4" type=cited from="[2005] FCA 788">evidence on technical and non-technical terms</citphrase>
<citphrase id="cp3.5" type=cited from="[2005] FCA 788">evidence on working of the embodiments</citphrase>
<citphrase id="cp3.6" type=cited from="[2005] FCA 788">relevance of description to construction of claim</citphrase>
<citphrase id="cp3.7" type=cited from="[2005] FCA 788">principles of infringement</citphrase>
<citphrase id="cp3.8" type=cited from="[2005] FCA 788">relevance of purposive construction</citphrase>
<citphrase id="cp3.9" type=cited from="[2005] FCA 788">catnic</citphrase>
<citphrase id="cp3.10" type=cited from="[2005] FCA 788">improver questions</citphrase>
<citphrase id="cp3.11" type=cited from="[2005] FCA 788">relevance of protocol questions</citphrase>
<citphrase id="cp3.12" type=cited from="[2005] FCA 788">it is not infringement to take substantial idea but not essential integers</citphrase>
<citphrase id="cp3.13" type=cited from="[2005] FCA 788">meaning of "pith and marrow"</citphrase>
<citphrase id="cp3.14" type=cited from="[2005] FCA 788">preferred embodiment not within claim 1</citphrase>
<citphrase id="cp3.15" type=cited from="[2005] FCA 788">claim not necessarily coexistent with inventive step</citphrase>
<citphrase id="cp3.16" type=cited from="[2005] FCA 788">limitation by result</citphrase>
<citphrase id="cp3.17" type=cited from="[2005] FCA 788">no infringement</citphrase>
<citphrase id="cp4.0" type=cited from="[2004] FCA 1658">patents</citphrase>
<citphrase id="cp4.1" type=cited from="[2004] FCA 1658">novelty</citphrase>
<citphrase id="cp4.2" type=cited from="[2004] FCA 1658">anticipation of specific chemical compound in an earlier broad claim</citphrase>
<citphrase id="cp4.3" type=cited from="[2004] FCA 1658">distinction between a general disclosure and a disclosure for novelty purposes</citphrase>
<citphrase id="cp4.4" type=cited from="[2004] FCA 1658">application by third party to appear amicus curiae in an appeal from delegate of commissioner of patents</citphrase>
<citphrase id="cp4.5" type=cited from="[2004] FCA 1658">refused</citphrase>
<citphrase id="cp4.6" type=cited from="[2004] FCA 1658">applicant's appeal allowed.</citphrase>
<citphrase id="cp5.0" type=cited from="[2002] HCA 59">aktiebolaget h&auml;ssle v alphapharm pty limited  patents</citphrase>
<citphrase id="cp5.1" type=cited from="[2002] HCA 59">revocation</citphrase>
<citphrase id="cp5.2" type=cited from="[2002] HCA 59">obviousness or lack of inventive step</citphrase>
<citphrase id="cp5.3" type=cited from="[2002] HCA 59">patent for an oral pharmaceutical preparation</citphrase>
<citphrase id="cp5.4" type=cited from="[2002] HCA 59">whether invention obvious and did not involve an inventive step having regard to what was known or used in australia on or before priority date</citphrase>
<citphrase id="cp5.5" type=cited from="[2002] HCA 59">combination of integers</citphrase>
<citphrase id="cp5.6" type=cited from="[2002] HCA 59">preparation arrived at by group of pharmaceutical chemists after period of experimental research</citphrase>
<citphrase id="cp5.7" type=cited from="[2002] HCA 59">whether hypothetical non-inventive worker in the field would have been led directly as a matter of course to pursue one avenue in expectation that it might well produce claimed invention</citphrase>
<citphrase id="cp5.8" type=cited from="[2002] HCA 59">relevance of publications discoverable by "routine literature search" but not found to have been part of the common general knowledge in australia at the priority date</citphrase>
<citphrase id="cp5.9" type=cited from="[2002] HCA 59">whether invention obvious if it was apparent to a non-inventive skilled worker that it would be "worthwhile to try" each of the integers that was ultimately successfully used</citphrase>
<citphrase id="cp5.10" type=cited from="[2002] HCA 59">relevance of attempts to replicate the process of invention by a skilled person aware of the desired result</citphrase>
<citphrase id="cp5.11" type=cited from="[2002] HCA 59">whether attempts futile.  appeal</citphrase>
<citphrase id="cp5.12" type=cited from="[2002] HCA 59">whether decision of primary judge in respect of obviousness affected by legal error</citphrase>
<citphrase id="cp5.13" type=cited from="[2002] HCA 59">where conclusions of primary judge affirmed by full court of the federal court.</citphrase>
<citphrase id="cp6.0" type=cited from="[2001] HCA 8">kimberly-clark australia pty ltd v arico trading international pty ltd  patents</citphrase>
<citphrase id="cp6.1" type=cited from="[2001] HCA 8">validity</citphrase>
<citphrase id="cp6.2" type=cited from="[2001] HCA 8">revocation</citphrase>
<citphrase id="cp6.3" type=cited from="[2001] HCA 8">whether invention sufficiently described</citphrase>
<citphrase id="cp6.4" type=cited from="[2001] HCA 8">whether complete specification includes claims</citphrase>
<citphrase id="cp6.5" type=cited from="[2001] HCA 8">whether sufficiency determined by reference to skilled addressee.</citphrase>
<citphrase id="cp9.0" type=cited from="[1994] FCA 1529">patents</citphrase>
<citphrase id="cp9.1" type=cited from="[1994] FCA 1529">method claims</citphrase>
<citphrase id="cp9.2" type=cited from="[1994] FCA 1529">product claims</citphrase>
<citphrase id="cp9.3" type=cited from="[1994] FCA 1529">infringement</citphrase>
<citphrase id="cp9.4" type=cited from="[1994] FCA 1529">authorisation</citphrase>
<citphrase id="cp9.5" type=cited from="[1994] FCA 1529">supply by defendant to third party</citphrase>
<citphrase id="cp9.6" type=cited from="[1994] FCA 1529">validity</citphrase>
<citphrase id="cp9.7" type=cited from="[1994] FCA 1529">fair basing</citphrase>
<citphrase id="cp9.8" type=cited from="[1994] FCA 1529">novelty</citphrase>
<citphrase id="cp9.9" type=cited from="[1994] FCA 1529">alleged prior publication in 1907</citphrase>
<citphrase id="cp9.10" type=cited from="[1994] FCA 1529">effect thereof</citphrase>
<citphrase id="cp9.11" type=cited from="[1994] FCA 1529">obviousness</citphrase>
<citphrase id="cp9.12" type=cited from="[1994] FCA 1529">double claiming</citphrase>
<citphrase id="cp9.13" type=cited from="[1994] FCA 1529">lack of title</citphrase>
<citphrase id="cp9.14" type=cited from="[1994] FCA 1529">false suggestion.</citphrase>
<citphrase id="cp10.0" type=cited from="[1993] FCA 404">patents</citphrase>
<citphrase id="cp10.1" type=cited from="[1993] FCA 404">compact low-pressure mercury vapour discharge lamp</citphrase>
<citphrase id="cp10.2" type=cited from="[1993] FCA 404">infringement of patent</citphrase>
<citphrase id="cp10.3" type=cited from="[1993] FCA 404">construction of "contains a luminescent material" in patent specification</citphrase>
<citphrase id="cp10.4" type=cited from="[1993] FCA 404">validity of patent</citphrase>
<citphrase id="cp10.5" type=cited from="[1993] FCA 404">sufficiency of description</citphrase>
<citphrase id="cp10.6" type=cited from="[1993] FCA 404">fair basing</citphrase>
<citphrase id="cp10.7" type=cited from="[1993] FCA 404">invention or manner of manufacture</citphrase>
<citphrase id="cp10.8" type=cited from="[1993] FCA 404">want of novelty</citphrase>
<citphrase id="cp10.9" type=cited from="[1993] FCA 404">utility</citphrase>
<citphrase id="cp10.10" type=cited from="[1993] FCA 404">effect of patents act 1990 on patents granted under patents act 1952</citphrase>
<citphrase id="cp10.11" type=cited from="[1993] FCA 404">revocation of patents granted under 1952 act using provision of 1990 act.</citphrase>
<citphrase id="cp11.0" type=cited from="[1991] FCA 567">trade practices</citphrase>
<citphrase id="cp11.1" type=cited from="[1991] FCA 567">s. 52</citphrase>
<citphrase id="cp11.2" type=cited from="[1991] FCA 567">effect of silence as to defect rendering use of goods sold illegal</citphrase>
<citphrase id="cp11.3" type=cited from="[1991] FCA 567">rhone-poulenc agrochimie sa v uim chemical services pty ltd distinguished</citphrase>
<citphrase id="cp11.4" type=cited from="[1991] FCA 567">misrepresentation by endorsement "pat pend" on goods not the subject of any patent application.  registered design</citphrase>
<citphrase id="cp11.5" type=cited from="[1991] FCA 567">whether obvious imitation or fraudulent imitation</citphrase>
<citphrase id="cp11.6" type=cited from="[1991] FCA 567">appearance to the eye</citphrase>
<citphrase id="cp11.7" type=cited from="[1991] FCA 567">copying deliberately disguised to avoid detection</citphrase>
<citphrase id="cp11.8" type=cited from="[1991] FCA 567">whether to show fraudulent imitation it is necessary to prove knowledge or suspicion that the design would be a registered design under australian law</citphrase>
<citphrase id="cp11.9" type=cited from="[1991] FCA 567">whether suspicion that it would be protected under some other form of intellectual property right would suffice.  patent</citphrase>
<citphrase id="cp11.10" type=cited from="[1991] FCA 567">continued application of patents act 1952</citphrase>
<citphrase id="cp11.11" type=cited from="[1991] FCA 567">whether petty patent was fairly based on provisional specification or complete specification from which it was divided</citphrase>
<citphrase id="cp11.12" type=cited from="[1991] FCA 567">principles of construction of specification</citphrase>
<citphrase id="cp11.13" type=cited from="[1991] FCA 567">doctrine of obviousness</citphrase>
<citphrase id="cp11.14" type=cited from="[1991] FCA 567">addition to old combination, whether invention of new combination</citphrase>
<citphrase id="cp11.15" type=cited from="[1991] FCA 567">weight of argument that patent was copied as soon as it was introduced as an indication of inventiveness, and qualification that such an argument assumes attempts were being made to overcome the problem solved by the patent</citphrase>
<citphrase id="cp11.16" type=cited from="[1991] FCA 567">ambiguity</citphrase>
<citphrase id="cp11.17" type=cited from="[1991] FCA 567">dictum of taylor j. that "it is right to construe a claim with an eye benevolent to the inventor and with a view to making the invention work"</citphrase>
<citphrase id="cp11.18" type=cited from="[1991] FCA 567">consideration of statements in claims as applicable to normal use of the invention rather than conditions of stress.  infringement</citphrase>
<citphrase id="cp11.19" type=cited from="[1991] FCA 567">taking of the substantial idea of the patent with a difference which was not material.</citphrase>
<citphrase id="cp12.0" type=cited from="[1989] FCA 297">patents</citphrase>
<citphrase id="cp12.1" type=cited from="[1989] FCA 297">infringement</citphrase>
<citphrase id="cp12.2" type=cited from="[1989] FCA 297">two patents for devices for cleaning the playing head of a cassette player</citphrase>
<citphrase id="cp12.3" type=cited from="[1989] FCA 297">whether the respondents' "flexibar" device replicates mechanical means, described in first patent, by which action of cassette player is converted to cleaning action</citphrase>
<citphrase id="cp12.4" type=cited from="[1989] FCA 297">whether "flexibar" device involves "a lever arm pivotally mounted in the container for reciprocating motion"</citphrase>
<citphrase id="cp12.5" type=cited from="[1989] FCA 297">whether a "lever arm" is an essential integer of appellants' first patent</citphrase>
<citphrase id="cp12.6" type=cited from="[1989] FCA 297">observations as to construction of claims in a complete specification</citphrase>
<citphrase id="cp12.7" type=cited from="[1989] FCA 297">meanings of "lever", "pivotally", "mounted", "reciprocating".  patents</citphrase>
<citphrase id="cp12.8" type=cited from="[1989] FCA 297">counter-claim for revocation of second of appellants' patents</citphrase>
<citphrase id="cp12.9" type=cited from="[1989] FCA 297">obviousness</citphrase>
<citphrase id="cp12.10" type=cited from="[1989] FCA 297">application of test stated by aickin j. in the wellcome foundation ltd v. vr laboratories (aust) pty ltd (1981) 148 clr 262 , 270</citphrase>
<citphrase id="cp12.11" type=cited from="[1989] FCA 297">discussion of characteristics possessed by hypothetical "worker in the field" and of the nature of "inventiveness"</citphrase>
<citphrase id="cp12.12" type=cited from="[1989] FCA 297">principles relating to "obviousness"</citphrase>
<citphrase id="cp12.13" type=cited from="[1989] FCA 297">question of fact</citphrase>
<citphrase id="cp12.14" type=cited from="[1989] FCA 297">relevance of known need/longfelt demand for, and substantial commercial success of, claimed invention.</citphrase>
<citphrase id="cp13.0" type=cited from="[1980] HCA 9">patents</citphrase>
<citphrase id="cp13.1" type=cited from="[1980] HCA 9">infringement</citphrase>
<citphrase id="cp13.2" type=cited from="[1980] HCA 9">counterclaim for revocation</citphrase>
<citphrase id="cp13.3" type=cited from="[1980] HCA 9">lack of inventive step</citphrase>
<citphrase id="cp13.4" type=cited from="[1980] HCA 9">obviousness</citphrase>
<citphrase id="cp13.5" type=cited from="[1980] HCA 9">combination patent</citphrase>
<citphrase id="cp13.6" type=cited from="[1980] HCA 9">test</citphrase>
<citphrase id="cp13.7" type=cited from="[1980] HCA 9">patents act 1952 (cth) s. 100 (1) (e).  procedure</citphrase>
<citphrase id="cp13.8" type=cited from="[1980] HCA 9">expert witness appointed by court</citphrase>
<citphrase id="cp13.9" type=cited from="[1980] HCA 9">function</citphrase>
<citphrase id="cp13.10" type=cited from="[1980] HCA 9">report</citphrase>
<citphrase id="cp13.11" type=cited from="[1980] HCA 9">questions submitted</citphrase>
<citphrase id="cp13.12" type=cited from="[1980] HCA 9">high court rules, o. 38, rr. 2, 3 (1), 5 (2).</citphrase>
<citphrase id="cp14.0" type=cited from="[1977] HCA 19">patent</citphrase>
<citphrase id="cp14.1" type=cited from="[1977] HCA 19">infringement</citphrase>
<citphrase id="cp14.2" type=cited from="[1977] HCA 19">counterclaim for revocation</citphrase>
<citphrase id="cp14.3" type=cited from="[1977] HCA 19">novelty</citphrase>
<citphrase id="cp14.4" type=cited from="[1977] HCA 19">prior user</citphrase>
<citphrase id="cp14.5" type=cited from="[1977] HCA 19">prior publication</citphrase>
<citphrase id="cp14.6" type=cited from="[1977] HCA 19">obviousness</citphrase>
<citphrase id="cp14.7" type=cited from="[1977] HCA 19">patents act 1952 (cth), s. 100 (1) (e), (g).</citphrase>
</citphrases>
<citances>
</citances>
<legistitles>
<title id="l0">PATENTS ACT 1990 </title>
<title id="l1">PATENTS ACT 1990 - SECT 18 Patentable inventions</title>
<title id="l2">PATENTS ACT 1990 - SECT 40 Specifications</title>
<title id="l3">PATENTS ACT 1990 - SECT 138 Revocation of patents in other circumstances</title>
<title id="l4">FEDERAL COURT RULES </title>
<title id="l5">PATENTS AMENDMENT ACT 2001 NO. 160, 2001 </title>
</legistitles>
</case>